WHO ICTRP trial
Efficacy evaluation of Toll-like receptor (TLR) 7 inhibitor using immune cells…
JPRN-UMIN000053738 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000053738 |
|---|---|
| Public title | Efficacy evaluation of Toll-like receptor (TLR) 7 inhibitor using immune cells derived from connective tissue disease patients |
| Scientific title | Efficacy evaluation of Toll-like receptor (TLR) 7 inhibitor using immune cells derived from connective tissue disease patients - Efficacy evaluation of Toll-like receptor (TLR) 7 inhibitor using immune cells derived from connective tissue disease patients |
| Primary sponsor | Toyama University |
| Secondary sponsors | Toyama Prefectural University Teika Pharmaceutical Co., Ltd. |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Patients with systemic lupus erythematosus (SLE) and other connective tissue diseases |
| Registration date | Jan 3, 2024 |
| Target size | 100 |
| Registry page | center6.umin.ac.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: